About Dongwha Pharm
Dongwha Pharm is a company based in Seoul (South Korea) founded in 1897. The company has 824 employees. Dongwha Pharm offers products and services including Pharmaceutical Drugs and Health Supplements.
- Headquarter Seoul, South Korea
- Employees 824
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website dong-wha.co.kr
- Social X
- Legal Name Dong Wha Pharm Co., Ltd.
- Annual Revenue$343.71 M (USD)6.78as on Dec 31, 2025
- Net Profit$6.02 M (USD)56.13as on Dec 31, 2025
- EBITDA$14.65 M (USD)-36.01as on Dec 31, 2025
- Employee Count824
Products & Services of Dongwha Pharm
Dongwha Pharm offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Health Supplements.
Manufacturing and selling of drugs for medical treatments is carried out by the company
Distribution of supplements for health maintenance is performed by the company
IPO & Listings of Dongwha Pharm
Dongwha Pharm is a publicly listed company on the KRX with ticker symbol 000020 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Mar 1976
- Listed onKRX: 20
- Listed entityDong Wha Pharm Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7000020008
- Share price5,360.00 KRW (-4.46% on the day) · 2026-10-08
- Market capitalisation148,568,103,943.00 KRW
- Price to earnings8.2
- EPS (diluted, trailing year)652.12 KRW
- Dividend yield1.21%
- Volume (last session)355,845
Financials of Dongwha Pharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 496.39B KRW | 8.69B KRW | 21.16B KRW |
| 2024 | 464.87B KRW | 5.56B KRW | 33.06B KRW |
| 2023 | 361.11B KRW | 27.44B KRW | 31.79B KRW |
| 2022 | 340.43B KRW | 20.38B KRW | 42.09B KRW |
| 2021 | 293.02B KRW | 17.87B KRW | 33.09B KRW |
Detailed financial statements for Dongwha Pharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Dongwha Pharm
The website of Dongwha Pharm (dong-wha.co.kr) receives about 36.6K visits a month.
- Monthly visits36.6K
▼ 19.1% vs previous month
Websites whose visitors overlap most with Dongwha Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| daewoong.co.kr | 100% | – | #252,331 | View details | |
pharm.or.kr | pharm.or.kr | 94% | – | #543,408 | β |
hanmi.co.kr | hanmi.co.kr | 91% | – | #470,713 | β |
| whanin.com | 91% | 74.9K | – | View details | |
| choa.co.kr | 90% | 14K | #1,738,079 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Dongwha Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Dongwha Pharm
Complete news archive for Dongwha Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Dongwha Pharm
10 companies that operate in the same segment as Dongwha Pharm (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dongwha Pharm
Dongwha Pharm was founded in 1897.
Dongwha Pharm is headquartered in Seoul, South Korea.
Dongwha Pharm has 824 employees.
Annual revenue of Dongwha Pharm is $343.71M as on Dec 31, 2025.
Dongwha Pharm was founded in 1897 in Seoul, South Korea, and operates within the pharmaceutical sector. Ethical drugs are produced, covering gastrointestinal agents, antibiotics, circulatory remedies, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies, genitourinary remedies, and anticancer agents. Over-the-counter drugs are also manufactured, including cold remedies, dental remedies, hepatic protectors, nutrients, tonics, topical analgesics, and anti-smoking agents. Pharmaceutical ingredients and healthcare food and drinks are provided additionally.
Dongwha Pharm offers Pharmaceutical Drugs and Health Supplements.
Yes, Dongwha Pharm is publicly traded on KRX under the ticker symbol 000020.
Dongwha Pharm operates through Donghwa Yakup, Inc.